Screener
Cogent Biosciences, Inc. COGT Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $6.25B.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 8:21 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205170
FAQ
- What is Cogent Biosciences, Inc.'s market capitalization?
- Cogent Biosciences, Inc. (COGT) reported market capitalization of $6.25B in Q1 2026.
- How has Cogent Biosciences, Inc.'s market capitalization changed year-over-year?
- Cogent Biosciences, Inc.'s market capitalization increased by 816.1% year-over-year, from $681.96M to $6.25B.
- What is the long-term trend for Cogent Biosciences, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s market capitalization has grown at a 64.9% compound annual growth rate (CAGR), from $447.53M to $5.45B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Cogent Biosciences, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude